Related Experiment Video
Updated: Jul 13, 2026

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
Published on: February 19, 2021
Dynamics of dot-like hemosiderin spots on T2*-weighted MRIs associated with stroke recurrence
Toshio Imaizumi1, Toshimi Honma, Yoshifumi Horita
1Department of Neurosurgery, Kushiro City General Hospital, Kushiro, Hokkaido, Japan. timaizum@d9.dion.ne.jp
Background And Purpose:
Dot-like low-intensity spots (dot-like hemosiderin spots: dotHSs) on gradient echo T2*-weighted (-w) brain magnetic resonance imaging (MRIs) are frequently associated with cerebral small vessel disease (SVD), including deep intracerebral hemorrhages and lacunar infarctions. This study investigated how numbers of newly appeared dotHSs contribute to recurrent SVD.
Methods:
We prospectively analyzed numbers of newly appeared dotHSs in 12 patients with prior SVD (8 males, 4 females; mean 67.6 +/- 10.7 years old) readmitted with recurring SVD between October 2001 and March 2003. Numbers of appeared dotHSs per year were counted on T2*-w MRI scans after SVD recurrence and compared to previous MRIs. Seventy-one outpatients (35 males, 36 females; mean 64.3 +/- 9.6 years old) with histories of intracerebral hemorrhages (ICH) that came to the hospital during the study period served as controls. The hazard ratio (HR) for recurrence was estimated from a multivariate logistic regression model, using the number of appeared dotHSs (per year) and other risk factors.
Results:
Multivariate analyses revealed that an elevated rate of recurrence was found in patients with substantial numbers of appeared dotHSs (>or=5/year) (HR, 7.34; P= 0.0008). We also analyzed factors associated with the numbers of appeared dotHSs. A number of appeared dotHSs (>or=5/year) was significantly and independently associated with the initial number of dotHSs (>or=10) on T2*-w MRIs following the first SVD (HR, 18.6; P= 0.0001).
Conclusions:
Though a small sample size limited the power of our analyses, our findings suggest that a number of newly appeared dotHSs may be associated with SVD recurrence.
Insights
Newly appearing dot-like hemosiderin spots (dotHSs) indicate a higher risk of recurrent cerebral small vessel disease (SVD). Monitoring dotHSs on MRI may help predict SVD progression and inform patient management strategies.
Area of Science:
- Neurology
- Radiology
- Vascular Medicine
Background:
- Dot-like hemosiderin spots (dotHSs) on T2*-weighted MRI are markers of cerebral small vessel disease (SVD).
- SVD encompasses conditions like intracerebral hemorrhages and lacunar infarctions.
- The association between newly developed dotHSs and SVD recurrence requires further investigation.
Purpose of the Study:
- To investigate the relationship between the number of newly appeared dotHSs and the recurrence of SVD.
- To identify potential predictors of SVD recurrence based on MRI findings.
Main Methods:
- Prospective analysis of 12 patients with recurrent SVD and 71 controls with a history of intracerebral hemorrhage.
- Quantification of newly appeared dotHSs per year on T2*-weighted MRI scans.
- Multivariate logistic regression to estimate the hazard ratio for recurrence, considering dotHSs and other risk factors.
Main Results:
- A substantial number of newly appeared dotHSs (>=5/year) was significantly associated with an elevated rate of SVD recurrence (HR, 7.34; P=0.0008).
- The initial number of dotHSs (>=10) independently predicted a higher rate of newly appeared dotHSs (HR, 18.6; P=0.0001).
Conclusions:
- The number of newly appeared dotHSs may serve as a potential indicator for SVD recurrence.
- Further research with larger sample sizes is warranted to confirm these findings and their clinical implications.
Related Concept Videos
Magnetic Resonance Imaging
Hemorrhagic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction

